External pharmaceutical composition for recovery after nervus peroneus communis injury

Abstract

invention is characterized by comprising the following active pharmaceutical ingredients in parts by weight: Solanum lyratum, rhizoma pleionis, schefflera arboricola, Herb of Paniculate Spotflower, securinega suffruticosa, mulberry seed, glossy privet fruit, immature bitter orange, Cassia alata, Glechoma longituba, Amblystegium serpens and Cladostachys amaranthoides. The clinical experiment proves that the invention has the characteristics of favorable curative effect and higher safety after nervus peroneus communis injury, and is worthy of clinical application and popularization.

Description

Technical field

[0001] The invention relates to the field of medicines, in particular to a pharmaceutical composition for external use for rehabilitation after injury of the common peroneal nerve. Background technique

[0002] The common peroneal nerve (nervus peroneus communis) bypasses the fibular neck and is superficial and close to the periosteum. Therefore, fibular neck fractures or improper use of fixation equipment may be involved, causing the calf extensor muscles to paralyze, leading to foot drop, and foot back Dysfunction of flexion and valgus, showing varus and drooping deformity. As well as the loss of thumb and toe extension, flexion, and sensory disturbances on the front and outside of the calf and the front and inside of the instep. Repairing the common peroneal nerve after injury is one of the difficult problems in the field of neurology. The essence of nerve regeneration is that damaged neurons form new axons, which can rebuild synaptic connections with target ...